News & Events
European Medicines Agency reviews safety of alemtuzumab
EMA conducts safety review of alemtuzumab (Lemtrada)
Cladribine approved in US for people with active secondary progressive MS
FDA approves cladribine for people with relapsing forms of MS and active secondary progressive MS
Treatment licensed in US for people with active secondary progressive MS
FDA approves the drug Siponimod, to treat people with active secondary progressive MS
How different disease modifying therapies can delay progression
A new study examined different disease modifying therapies and their ability to slow the onset of secondary…
Treating MS in pregnancy
MS affects at least twice as many more women than men, and it often strikes at an…
Screening environmental chemicals that may influence MS
976 chemicals were screened to assess their impact on MS.
Stem cell trial results published
A trial has compared a cancer chemotherapy to MS treatments, but further research is needed to understand…
Let’s talk about sex and MS
We have collaborated with our members to adapt an animation that addresses some of the challenges of…
EME’s Tips to Help Quality of Life
Multiple Sclerosis Spain has launched a new illustration with tips to help improve quality of life for…
Against MS Launches Worldwide
Against MS is the DIY fundraising initiative for the MS International Federation because as the leaders of…
Chair of the People with MS Advisory Committee awarded for his services to MS
Martin Stevens is awarded for his services to people with MS
Results released from first multi-drug clinical trial in MS
The results of the MS-SMART trial, an innovative trial testing multiple drugs at the same time, have…